J
Jeffrey D. Wayne
Researcher at Northwestern University
Publications - 97
Citations - 8247
Jeffrey D. Wayne is an academic researcher from Northwestern University. The author has contributed to research in topics: Sentinel lymph node & Cancer. The author has an hindex of 38, co-authored 87 publications receiving 7318 citations. Previous affiliations of Jeffrey D. Wayne include Vanderbilt University & University of Chicago.
Papers
More filters
Journal ArticleDOI
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors
George D. Demetri,Margaret von Mehren,Cristina R. Antonescu,Ronald P. DeMatteo,Kristen N. Ganjoo,Robert G. Maki,Peter W.T. Pisters,Chandrajit P. Raut,Richard F. Riedel,Scott M. Schuetze,Hema Sundar,Jonathan C. Trent,Jeffrey D. Wayne +12 more
TL;DR: The standard of care for managing patients with gastrointestinal stromal tumors (GISTs) rapidly changed after the introduction of effective molecularly targeted therapies involving tyrosine kinase inhibitors (TKIs), such as imatinib mesylate and sunitinib malate.
Journal ArticleDOI
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Mark B. Faries,John F. Thompson,Alistair J. Cochran,Robert H.I. Andtbacka,Nicola Mozzillo,Jonathan S. Zager,Tiina Jahkola,Tawnya L. Bowles,Alessandro Testori,Peter D. Beitsch,Harald J. Hoekstra,Marc Moncrieff,Christian Ingvar,Michel W.J.M. Wouters,Michael S. Sabel,Edward A. Levine,Doreen M. Agnese,Michael A. Henderson,Reinhard Dummer,Carlo Riccardo Rossi,Rogerio I. Neves,Steven D. Trocha,Frances C. Wright,David R. Byrd,Maurice Matter,Eddy Hsueh,Alastair MacKenzie-Ross,Douglas B. Johnson,Patrick Terheyden,Adam C. Berger,Tara L. Huston,Jeffrey D. Wayne,B. Mark Smithers,Heather B. Neuman,Schlomo Schneebaum,Jeffrey E. Gershenwald,Charlotte E. Ariyan,Darius C. Desai,Lisa K. Jacobs,Kelly M. McMasters,Anja Gesierich,Peter Hersey,Steven D. Bines,John M. Kane,Richard J. Barth,Gregory McKinnon,Jeffrey M. Farma,Erwin S. Schultz,Sergi Vidal-Sicart,Richard A. Hoefer,James M. Lewis,Randall P. Scheri,Mark C. Kelley,Omgo E. Nieweg,R. Dirk Noyes,Dave S.B. Hoon,He-Jing Wang,David Elashoff,Robert Elashoff +58 more
TL;DR: Immediate completion lymph‐node dissection increased the rate of regional disease control and provided prognostic information but did not increase melanoma‐specific survival among patients with melanoma and sentinel‐node metastases.
Journal ArticleDOI
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren,R. Lor Randall,Robert S. Benjamin,Sarah Boles,Marilyn M. Bui,Ernest U. Conrad,Kristen N. Ganjoo,Suzanne George,Ricardo J. Gonzalez,Martin J. Heslin,John M. Kane,Henry B. Koon,Joel L. Mayerson,Martin D. McCarter,Sean V. McGarry,Christian F. Meyer,Richard J. O'Donnell,Alberto S. Pappo,I. Benjamin Paz,Ivy A. Petersen,John D. Pfeifer,Richard F. Riedel,Scott M. Schuetze,Karen D. Schupak,Herbert S. Schwartz,William D. Tap,Jeffrey D. Wayne,Mary Anne Bergman,Jillian L. Scavone +28 more
TL;DR: This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.
Journal ArticleDOI
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.
George D. Demetri,Robert S. Benjamin,Charles D. Blanke,Jean-Yves Blay,Paolo G. Casali,Haesun Choi,Christopher L. Corless,Maria Debiec-Rychter,Ronald P. DeMatteo,David S. Ettinger,George A. Fisher,Christopher D.M. Fletcher,Alessandro Gronchi,Peter Hohenberger,Miranda Hughes,Heikki Joensuu,Ian Judson,Axel Le Cesne,Robert G. Maki,Michael A. Morse,Alberto S. Pappo,Peter W.T. Pisters,Chandrajit P. Raut,Peter Reichardt,Douglas S. Tyler,Annick D. Van den Abbeele,Margaret von Mehren,Jeffrey D. Wayne,John Zalcberg +28 more
TL;DR: The GIST Task Force met for the first time in October 2003 and again in December 2006 with the purpose of expanding on the existing NCCN guidelines for gastrointestinal sarcomas and identifying areas of future research to optimize the understanding and treatment of GIST.
Journal ArticleDOI
Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years.
Karl Y. Bilimoria,David J. Bentrem,Jeffrey D. Wayne,Clifford Y. Ko,Clifford Y. Ko,Charles L. Bennett,Mark S. Talamonti,Mark S. Talamonti +7 more
TL;DR: The overall incidence of small intestine malignancies has increased considerably, primarily because of carcinoid tumors which are now the most common small bowel cancer.